Table 4.

High- risk HPV-positive patients’ characteristics.

Reason for Immunosuppressive Therapy Use	Number of High-Risk HPV-Positive Women	Duration of Immunotherapy (Months)	Immunosuppressive Therapy
Renal transplantation	18	105.4 ± 58.3	Tac, MMF, steroids = 9 (50%) Tac, steroids = 3 (16.7%) Other = 6 (33.3%)
Liver transplantation	6	63.7 ± 57.1	CsA, MMF, steroids = 3 (50%) Tac, MMF, steroids = 2 (33.3%) Tac, steroids = 1 (16.7%)
Other diseases 1	2	186.0 ± 144.2	MMF, Aza, steroids = 1 (50%) CsA, steroids = 1 (50%)

HPV—human papillomavirus; Tac—tacrolimus; MMF—mycophenolate mofetil; CsA—cyclosporine A; Aza—azathioprine; steroids—prednisone or methylprednisolone; ¹ systemic lupus erythematosus and chronic glomerulonephritis.